-
Mashup Score: 2Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer - Full Text View - ClinicalTrials.gov - 1 year(s) ago
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer – Full Text View.
Source: www.clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
A Multicenter, Phase 1, Open-label, Dose-escalation and Expansion Study of AMG 340, a Bispecific Antibody Targeting PSMA in Subjects with Metastatic Castrate-Resistant Prostate CarcinomaThis is a phase 1, open-label study evaluating the safety, clinical pharmacology and clinical activity of AMG 340, a PSMA x CD3 T-cell engaging bispecific antibody, in subjects with metastatic castrate-resistant…
Source: www.jeffersonhealth.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer – Full Text View.
Source: www.clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma – Full Text View.
Source: www.clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Uveal or #OcularMelanoma is a rare, aggressive tumor of the eye. Dr. Marlana Orloff is PI of a phase 1/1b study of the investigational drug SD-101 alone or with an immune checkpoint blockade to treat metastatic #UvealMelanoma. #TrialTuesday #RareDiseaseDay https://t.co/CkFCXihM7F https://t.co/CN6GEkHO2i
-
-
Mashup Score: 0
Study Comparing Investigational Drug HBI-8000 Combined With Nivolumab vs. Nivolumab in Patients With Advanced Melanoma – Full Text View.
Source: www.clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#TrialTuesday: A phase III trial led by Dr. Rino Seedor is studying the safety & efficacy of the investigational drug HBI-8000 combined w/ the immunotherapy drug nivolumab compared with nivolumab plus placebo in patients with metastatic #melanoma @bmsnews https://t.co/IlzgHfATJJ https://t.co/6CZ3XHCaLx
-
-
Mashup Score: 0
Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment – Full Text View.
Source: www.clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Dr. Grace Lu-Yao is leading a #ClinicalTrial evaluating an at-home exercise program for people undergoing immunotherapy. Increasing physical activity may help reduce fatigue, improve mood, increase physical performance & decrease joint pain. #TrialTuesday https://t.co/bVSnLNRPj1 https://t.co/OE422EWmDE
-
-
Mashup Score: 0
Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use – Full Text View.
Source: www.clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Copyright © 2023 Thomas Jefferson University Hospitals. All Rights Reserved. Jefferson holds itself accountable, at every level of the organization, to nurture an environment of inclusion and respect, by valuing the uniqueness of every individual, celebrating and reflecting the rich diversity of its communities, and taking meaningful action to cultivate an environment of fairness, belonging &…
Source: www.jeffersonhealth.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#TrialTuesday: Dr. Adam Luginbuhl @Jefferson_OTO is evaluating whether immunotherapy before surgery & after surgery along w/ radiotherapy for head & neck squamous cell carcinoma is more effective than post-surgery radiotherapy alone #ClinicalTrial @Merck https://t.co/6afZvDFWcS https://t.co/IJzgbNkrYp
-
-
Mashup Score: 0
OLDER NON-SMALL CELL LUNG CANCER PATIENTS (>/= 70 YEARS OF AGE) TREATED WITH FIRST-LINE MK-3475 (PEMBROLIZUMAB) +/- CHEMOTHERAPY (ONCOLOGIST S/PATIENT S CHOICE)This trial studies the side effects of pembrolizumab with or without chemotherapy in treating patients with stage IV non-small cell lung cancer that has come back (recurrent) and has spread to other places in the body (advanced)….
Source: www.jeffersonhealth.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#TrialTuesday: Dr. Sarah Gordon is SKCC's PI of @ALLIANCE_org-sponsored #ClinicalTrial studying #immunotherapy –which may help the body's immune system attack the cancer– with & without chemo in older patients with advanced non-small cell lung cancer #lcsm https://t.co/vJEYJBnqyD https://t.co/bgGP7DNmH0
-
-
Mashup Score: 3Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer - Full Text View - ClinicalTrials.gov - 1 year(s) ago
Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer – Full Text View.
Source: www.clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
#TrialTuesday: Dr. Jennifer Johnson is leading a #ClinicalTrial investigating maintenance immunotherapy following radiation and chemotherapy for #HPV + throat cancer that has spread to nearby tissue or lymph nodes. https://t.co/YShtYmZzXI #HeadAndNeckCancerAwarenessMonth https://t.co/OlTuTE8mTz